Pure Global AI
CDSCO UID IMP/IVD/2022/000152_fbc88ca04fa7e4df9378c06a48309eb6_d74e5490ed7895f2529898025ba464b4

EUROLINE Anti-Gangliosides-Profile 2

M/s. CPC Diagnostics Pvt LtdDevice Class Class BIndia CDSCOBrand: NIL
VerifiedCDSCO · official registry
Registration details
UID
IMP/IVD/2022/000152_fbc88ca04fa7e4df9378c06a48309eb6_d74e5490ed7895f2529898025ba464b4
Device class
Class B
Brand name
NIL
License holder
M/s. CPC Diagnostics Pvt Ltd
Approving authority
CDSCO
Product information
The EUROLINE test kit provides qualitative in vitro determination of human autoantibodies of the immunoglobulin class IgG to the seven gangliosides GM1, GM2, GM3, GD1a, GD1b, GT1b and GQ1b in serum or plasma to support the diagnosis of Guillain-Barre syndrome (NIL), chronic inflammatory demyelinating polyneuropathy (NIL), multifocal motor neuropathy (NIL), sensory neuropathy and Miller-Fisher syndrome (NIL)
About this record

EUROLINE Anti-Gangliosides-Profile 2 is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2022/000152_fbc88ca04fa7e4df9378c06a48309eb6_d74e5490ed7895f2529898025ba464b4. This device is marketed under the brand name NIL. The license holder is M/s. CPC Diagnostics Pvt Ltd, and it is classified as Device Class Class B. The approving authority is CDSCO.

This page provides the facts attached to this CDSCO registry row. Other records from the same license holder are available through the database search link without adding aggregation queries to this page. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.